James R. Engle

Technik-/Wissenschafts-/F&E-Leiter bei Talecris Biotherapeutics Holdings Corp.

68 Jahre

Health Technology

Consumer Services

Aktive Positionen von James R. Engle

Unternehmen	Position	Beginn	Ende
Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.	Technik-/Wissenschafts-/F&E-Leiter	24.03.2010	-
	Corporate Officer/Principal	24.03.2010	24.03.2010

Unternehmen	Position	Beginn	Ende
Aventis, Inc.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2004	01.01.2004
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.	Technik-/Wissenschafts-/F&E-Leiter	-	-

Delaware Valley University

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
Undergraduate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.	Health Technology
Aventis, Inc.
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.	Health Technology